A double‐blind, randomized, placebo‐controlled phase 2 trial evaluating the selective dihydroorotate dehydrogenase inhibitor vidofludimus calcium in relapsing‐remitting multiple sc...

por Fox, Robert J., Wiendl, Heinz, Wolf, Christian, De Stefano, Nicola, Sellner, Johann, Gryb, Viktoriia, Rejdak, Konrad, Bozhinov, Plamen Stoyanov, Tomakh, Nataliya, Skrypchenko, Iryna, Muehler, Andreas R.
Publicado 2022